| |
| |
|
| Insider
Information: |
Callicutt Jack W |
| Relationship: |
|
| City: |
Atlanta |
| State: |
GA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
8,614 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$25,431 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
8,614 |
|
|
| Total
Value |
$25,431 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
| Percentage
Gain/Loss : |
 5.9%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Corautus Genetics Inc |
VEGF |
VP-Finance&Admin, Chf ... |
2004-05-07 |
1,000 |
2004-05-07 |
0 |
Premium* |
|
|
Galectin Therapeutics Inc |
GALT |
|
2022-11-17 |
7,614 |
2013-11-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
19 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GALT |
Galectin Therapeutics Inc |
Chief Financial Officer |
• • – |
2022-11-17 |
4 |
B |
$1.32 |
$5,280 |
D/D |
4,000 |
7,614 |
0.01 |
% |
|
| GALT |
Galectin Therapeutics Inc |
Chief Financial Officer |
• – – |
2019-05-31 |
4 |
B |
$4.28 |
$10,075 |
D/D |
2,354 |
3,614 |
2.74 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Chief Financial Officer |
• – – |
2018-06-20 |
4 |
S |
$8.08 |
$786,034 |
D/D |
(97,267) |
1,260 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Chief Financial Officer |
• – – |
2018-06-20 |
4 |
OE |
$4.41 |
$428,947 |
D/D |
97,267 |
98,527 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Chief Financial Officer |
• – – |
2018-06-19 |
4 |
S |
$9.01 |
$1,159,987 |
D/D |
(128,733) |
1,260 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Chief Financial Officer |
• – – |
2018-06-19 |
4 |
OE |
$3.45 |
$542,753 |
D/D |
128,733 |
129,993 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Chief Financial Officer |
• – – |
2018-06-12 |
4 |
AS |
$7.01 |
$65,167 |
D/D |
(9,294) |
1,260 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Chief Financial Officer |
• – – |
2018-06-12 |
4 |
OE |
$1.37 |
$12,733 |
D/D |
9,294 |
10,554 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Chief Financial Officer |
• – – |
2018-06-11 |
4 |
AS |
$6.38 |
$127,500 |
D/D |
(20,000) |
1,260 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Chief Financial Officer |
• – – |
2018-06-11 |
4 |
OE |
$1.37 |
$27,400 |
D/D |
20,000 |
21,260 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Chief Financial Officer |
• – – |
2018-06-08 |
4 |
AS |
$5.75 |
$575,000 |
D/D |
(100,000) |
1,260 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Chief Financial Officer |
• – – |
2018-06-08 |
4 |
OE |
$0.87 |
$87,000 |
D/D |
100,000 |
101,260 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Chief Financial Officer |
• – – |
2018-05-31 |
4 |
AS |
$5.00 |
$233,255 |
D/D |
(46,651) |
1,260 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Chief Financial Officer |
• – – |
2018-05-31 |
4 |
OE |
$0.87 |
$40,586 |
D/D |
46,651 |
47,911 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Chief Financial Officer |
• – – |
2018-04-04 |
4 |
AS |
$5.00 |
$16,745 |
D/D |
(3,349) |
1,260 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Chief Financial Officer |
• – – |
2018-04-04 |
4 |
OE |
$0.87 |
$2,914 |
D/D |
3,349 |
4,609 |
0 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Chief Financial Officer |
• – – |
2014-08-14 |
4 |
B |
$4.55 |
$4,545 |
D/D |
1,000 |
1,260 |
2.66 |
- |
|
| GALT |
Galectin Therapeutics Inc |
Chief Financial Officer |
• – – |
2013-11-19 |
4 |
B |
$6.25 |
$1,625 |
D/D |
260 |
260 |
2.66 |
- |
|
| VEGF |
Corautus Genetics Inc |
VP-Finance&Admin, Chf Acct Off |
• – – |
2004-05-07 |
4 |
B |
$5.50 |
$5,500 |
D/D |
1,000 |
1,000 |
2.74 |
- |
|
19 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
